MetaCap

Polaryx Therapeutics Insider Trades

NASDAQ: PLYXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.33-0.18 (-11.92%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
2 · $367.99K
Sales
0 · $0
Shares bought / sold
91.32K / 0
Net activity
Net buying $367,994

Polaryx Therapeutics insider activity

Over the last 12 months, Polaryx Therapeutics insiders reported 2 transactions on SEC Form 4: 2 open-market purchases and 0 sales. Insiders bought $367,994 and sold $0 worth of stock, for net insider buying of $367,994. The most recent filing shows Yang Alex Keun Mo & Mstone Partners Healthcare Ltd (Chief Executive Officer) buying 88,453 shares at $4.07 on May 27, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put PLYX's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

PLYX insider transactions

Polaryx Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
May 27, 2026Yang Alex Keun Mo & Mstone Partners Healthcare LtdChief Executive OfficerBuy88,453$360.00KForm 4
Feb 18, 2026Landis G. MichaelChief Financial OfficerBuy2,867$7.99KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related